Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates
暂无分享,去创建一个
Takao K Hensch | Whitney M. Weikum | Michael S Kobor | Janet F Werker | Manel Esteller | T. Hensch | J. Werker | M. Esteller | T. Oberlander | M. Kobor | Sarah J. Goodman | Ignacio Martin-Subero | Cécile Gurnot | U. Brain | S. Mah | Tim F Oberlander | Sarah J Goodman | Cécile Gurnot | Ignacio Martin-Subero | Sarah M Mah | Whitney Weikum | Ursula Brain | I. Martin-Subero
[1] S. Murphy,et al. Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight , 2012, Cancer Causes & Control.
[2] S. Davis,et al. Effect of fasting and obesity in humans on the 6‐hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity , 1994, Clinical pharmacology and therapeutics.
[3] Eldon Emberly,et al. Factors underlying variable DNA methylation in a human community cohort , 2012, Proceedings of the National Academy of Sciences.
[4] Isaac S. Kohane,et al. Prenatal antidepressant exposure is associated with risk for attention deficit-hyperactivity disorder but not autism spectrum disorder in a large health system , 2014, Molecular Psychiatry.
[5] D. Popa,et al. Lasting Syndrome of Depression Produced by Reduction in Serotonin Uptake during Postnatal Development: Evidence from Sleep, Stress, and Behavior , 2008, The Journal of Neuroscience.
[6] A. Gilbert,et al. Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy , 2011, Drug safety.
[7] Hui Xie,et al. Altered Cytochrome P450 Expression in Mice during Pregnancy , 2011, Drug Metabolism and Disposition.
[8] Carmen J. Marsit,et al. miR-16 and miR-21 Expression in the Placenta Is Associated with Fetal Growth , 2011, PloS one.
[9] M. Merzenich,et al. Perinatal antidepressant exposure alters cortical network function in rodents , 2011, Proceedings of the National Academy of Sciences.
[10] K. Conneely,et al. DNA methylation in neonates born to women receiving psychiatric care , 2012, Epigenetics.
[11] Emma Y. Wu,et al. A Role for Repressive Histone Methylation in Cocaine-Induced Vulnerability to Stress , 2011, Neuron.
[12] Teri E. Klein,et al. Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process , 2014, Current drug metabolism.
[13] A. Gilbert,et al. Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors , 2012, Journal of clinical psychopharmacology.
[14] E. Moreira,et al. Behavioral Evaluation of Male and Female Mice Pups Exposed to Fluoxetine during Pregnancy and Lactation , 2007, Pharmacology.
[15] T. Oberlander,et al. Prenatal Exposure to Maternal Depressed Mood and the MTHFR C677T Variant Affect SLC6A4 Methylation in Infants at Birth , 2010, PloS one.
[16] R. Desnick,et al. Multi-ethnic Cytochrome-P450 Copy Number Profiling: Novel Pharmacogenetic Alleles and Mechanism of Copy Number Variation Formation , 2012, The Pharmacogenomics Journal.
[17] T. Bale,et al. Sex-Specific Programming of Offspring Emotionality after Stress Early in Pregnancy , 2008, The Journal of Neuroscience.
[18] Michael Papsdorf,et al. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses , 2008, Epigenetics.
[19] T. Oberlander,et al. Neurodevelopmental outcomes following prenatal exposure to serotonin reuptake inhibitor antidepressants: a "social teratogen" or moderator of developmental risk? , 2012, Birth defects research. Part A, Clinical and molecular teratology.
[20] T. Cresteil,et al. Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period. , 1996, European journal of biochemistry.
[21] C. Perret,et al. Fetal and maternal CYP2E1 genotypes and the risk of nonsyndromic oral clefts , 2007, American journal of medical genetics. Part A.
[22] G. de Sousa,et al. Tissue-specific expression and methylation of the human CYP2E1 gene. , 1994, Biochemical pharmacology.
[23] R. Hen,et al. Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice , 2004, Science.
[24] F. Champagne,et al. Epigenetic Effects of Prenatal Stress on 11β-Hydroxysteroid Dehydrogenase-2 in the Placenta and Fetal Brain , 2012, PloS one.
[25] U. Wüllner,et al. Genome-scale methylation analysis of Parkinson's disease patients' brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1 , 2012, neurogenetics.
[26] M Farlow,et al. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. , 1992, JAMA.
[27] J. Seckl,et al. Differential regulation of variant glucocorticoid receptor mRNAs in the rat hippocampus by the antidepressant fluoxetine. , 2004, Brain research. Molecular brain research.
[28] C. De las Cuevas,et al. Safety of selective serotonin reuptake inhibitors in pregnancy , 2007 .
[29] L. Bertilsson,et al. Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy. , 2004, Therapeutic drug monitoring.
[30] Kamil Kuca,et al. Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease. , 2008, Current drug metabolism.
[31] Takao K Hensch,et al. Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception , 2012, Proceedings of the National Academy of Sciences.
[32] C. Lieber,et al. Induction of cytochrome P450IIE1 in the obese overfed rat. , 1991, Molecular pharmacology.
[33] H. Malm,et al. Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). , 2010, Reproductive toxicology.
[34] I. Hertz-Picciotto,et al. Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay , 2014, Pediatrics.
[35] A. P. Shaik,et al. Meta-analysis study of glutathione-S-transferases (GSTM1, GSTP1, and GSTT1) gene polymorphisms and risk of acute myeloid leukemia , 2009, Leukemia & lymphoma.
[36] F. A. Schroeder,et al. Setdb1 Histone Methyltransferase Regulates Mood-Related Behaviors and Expression of the NMDA Receptor Subunit NR2B , 2010, The Journal of Neuroscience.
[37] F. A. Schroeder,et al. Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse , 2007, Biological Psychiatry.
[38] M. Forman,et al. The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring , 2011, Clinical Epigenetics.
[39] Anthony P. Fejes,et al. DNA methylation, genotype and gene expression: who is driving and who is along for the ride? , 2013, Genome Biology.
[40] M. Ingelman-Sundberg,et al. The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model. , 2009, Journal of hepatology.
[41] C. Connor,et al. Setdb 1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit , 2017 .
[42] Yonghua Hu,et al. Cytochrome P450 gene polymorphisms and risk of low birth weight , 2005, Genetic epidemiology.
[43] Emma Y. Wu,et al. Antidepressant Actions of Histone Deacetylase Inhibitors , 2009, The Journal of Neuroscience.
[44] Lang Li,et al. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. , 2003, British journal of clinical pharmacology.
[45] R. Duman,et al. Chromatin Remodeling: A Novel Mechanism of Psychotropic Drug Action , 2006, Molecular Pharmacology.
[46] J. Morrison,et al. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens , 2010, Nature Neuroscience.
[47] R. Steer,et al. Self-reported depression and negative pregnancy outcomes. , 1992, Journal of clinical epidemiology.
[48] T. Field,et al. CHRONIC PRENATAL DEPRESSION AND NEONATAL OUTCOME , 2008, The International journal of neuroscience.
[49] E. Sellers,et al. Inhibition by fluoxetine of cytochrome P450 2D6 activity , 1993, Clinical pharmacology and therapeutics.
[50] Defeng Wu,et al. Role of oxidative stress in alcohol-induced liver injury , 2009, Archives of Toxicology.
[51] M. Smidt,et al. Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities , 2008, PloS one.
[52] Even chromatin gets the blues , 2006, Nature Neuroscience.
[53] Z. Dong,et al. Mechanism of induction of cytochrome P-450ac (P-450j) in chemically induced and spontaneously diabetic rats. , 1988, Archives of biochemistry and biophysics.
[54] M. Ingelman-Sundberg,et al. Structural and functional characterization of the 5'-flanking region of the rat and human cytochrome P450 2E1 genes: identification of a polymorphic repeat in the human gene. , 1999, Biochemical and biophysical research communications.
[55] Satish Iyengar,et al. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. , 2010, Archives of general psychiatry.
[56] Lucie Blais,et al. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. , 2007, Birth defects research. Part B, Developmental and reproductive toxicology.
[57] P. Cau,et al. Hypomethylation and hypoexpression of human CYP2E1 gene in lung tumors. , 1994, Biochemical and biophysical research communications.
[58] J. Launay,et al. MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants , 2010, Science.
[59] C. Mulligan,et al. Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and newborn birth weight , 2012, Epigenetics.
[60] T. Oberlander,et al. Fetal Serotonin Reuptake Inhibitor Antidepressant Exposure: Maternal and Fetal Factors , 2012, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[61] T. Field,et al. Prenatal depression restricts fetal growth. , 2009, Early human development.
[62] Richard Mayeux,et al. Clinical practice. Early Alzheimer's disease. , 2010, The New England journal of medicine.
[63] Takayoshi Suzuki,et al. Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events , 2011, Neuron.
[64] T. Field,et al. Prenatal depression effects on the fetus and newborn: a review. , 2006, Infant behavior & development.
[65] K. Doi,et al. Effects of pregnancy on CYPs protein expression in rat liver. , 2005, Experimental and molecular pathology.
[66] J. Zwiller,et al. Fluoxetine and Cocaine Induce the Epigenetic Factors MeCP2 and MBD1 in Adult Rat Brain , 2006, Molecular Pharmacology.
[67] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[68] V. Glover,et al. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? , 2007, Journal of child psychology and psychiatry, and allied disciplines.
[69] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[70] A. Boobis,et al. Expression of CYP2E1 during human fetal development: methylation of the CYP2E1 gene in human fetal and adult liver samples. , 1992, Biochemical pharmacology.
[71] F. Gonzalez,et al. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. , 2005, Mutation research.
[72] B. H. Miller,et al. Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains , 2011, Psychopharmacology.
[73] Y. Saijo,et al. Adverse birth outcomes associated with maternal smoking and polymorphisms in the N-Nitrosamine-metabolizing enzyme genes NQO1 and CYP2E1. , 2007, American journal of epidemiology.
[74] E. Nestler,et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.
[75] Claudia H. Kawas,et al. Early Alzheimer's Disease , 2003 .
[76] P. Svenningsson,et al. Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. , 2012, The international journal of neuropsychopharmacology.
[77] R. Weksberg,et al. WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate , 2011, Epigenetics.
[78] C. Hertzman,et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.
[79] Alexandra M. Binder,et al. Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy , 2014, Epigenetics.
[80] O. Maksymchuk,et al. The impact of psychogenic stressors on oxidative stress markers and patterns of CYP2E1 expression in mice liver. , 2012, Pathophysiology : the official journal of the International Society for Pathophysiology.
[81] Jeffrey T Leek,et al. The optimal discovery procedure for large-scale significance testing, with applications to comparative microarray experiments. , 2007, Biostatistics.
[82] M. Weissman,et al. Children of depressed mothers 1 year after the initiation of maternal treatment: findings from the STAR*D-Child Study. , 2008, The American journal of psychiatry.
[83] H. Eom,et al. Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma. , 2010, Cancer genetics and cytogenetics.
[84] C. Marsit,et al. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta , 2011, Epigenetics.